Pablo Táboas Outón
Investigador pre-doc
Research group
Research line:
Epigenetics of Rhabdomyosarcoma
Pablo Táboas graduated in Biology from the University of Santiago de Compostela in 2018 and obtained his Master's degree in Biomedicine from the University of Barcelona in 2019.
Currently, he is pursuing a PhD in Biomedicine at the University of Barcelona under the supervision of Dr. Jaume Mora and Dr. Sara Sánchez-Molina, studying the epigenetic deregulations that occur in Rhabdomyosarcoma, funded by a P-FIS grant from the Carlos III Health Institute.
During the year 2024, he will undertake a stay at the German Cancer Research Center (DKFZ) in Heidelberg (Germany).
Professional network profiles
Last Publications
- Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano P, Pérez-Jaume S, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma Biorxiv . : .
- Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis Science Advances . 6(43): 3058.
Projects
- Project name:
- Contratos predoctorales de formación en investigación en salud_Beneficiari: Pablo Taboas
- Leader
- Jaume Mora Graupera
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- FI21/00047
- Starting - finishing date:
- 2022 - 2025
- Project name:
- SGR 2022-2024_Grup de recerca en tumors del desenvolupament
- Leader
- Jaume Mora Graupera
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 01612
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Influencia del contexto epigenético en la edad como factor pronóstico en Ewing Sarcoma
- Leader
- Jaume Mora Graupera
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI20/00179
- Starting - finishing date:
- 2021 - 2023